A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of North India

A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of... World J Urol (2017) 35:1233–1240 DOI 10.1007/s00345-016-1980-6 ORIGINAL ARTICLE A double‑blind, placebo‑controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of North India 1 1 Ankur Bansal · Aditi Arora Received: 30 September 2016 / Accepted: 29 November 2016 / Published online: 19 December 2016 © Springer-Verlag Berlin Heidelberg 2016 Abstract Conclusions 0.1% tranexamic acid in irrigant fluid is safe Purpose To evaluate the efficacy and safety of 0.1% and significantly reduces perioperative blood loss and tranexamic acid in irrigant fluid in reducing blood loss dur - requirement of blood transfusion during percutaneous ing PCNL. nephrolithotomy. It is associated with lower perioperative Materials and methods The study involved 400 patients complication rates. who were planned for PCNL and were prospectively ran- domized into two equal groups. In tranexamic group, 0.1% Keywords Percutaneous nephrolithotomy · Tranexamic tranexamic acid was given in irrigant fluid, while in pla - acid · Irrigant · Blood loss cebo group, distilled water was added to irrigant fluid dur - ing surgery. Operative data were recorded which included Abbreviations fall in hemoglobin, total blood loss, operative time, irriga-PCNL http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png World Journal of Urology Springer Journals

A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of North India

Loading next page...
 
/lp/springer_journal/a-double-blind-placebo-controlled-randomized-clinical-trial-to-dPUVwUez9E
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2016 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Urology; Nephrology; Oncology
ISSN
0724-4983
eISSN
1433-8726
D.O.I.
10.1007/s00345-016-1980-6
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial